IRVINE, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of...
JenaValve Raises $62.5 Million In Venture Funding Capital to Fund Clinical Study for Transfemoral TAVI system, Expansion of Commercial...
Seed developer sells subordinated notes that will convert to stock in its IPO --Purchasers will receive a 20% discount from the IPO price --Artal...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads